Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem Buys America's 1st Choice, Expands in Medicare Market
by Zacks Equity Research
Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.
Molina Healthcare (MOH) Tops on Q4 Earnings, Issues '18 View
by Zacks Equity Research
Restructuring costs and impairment loss affect Molina Healthcare's (MOH) fourth-quarter results.
The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cigna, Burlington Stores and Anthem
3 Stable Low-Beta Stocks to Buy During Volatile Markets
by Benjamin Rains
Markets began to rebound on Monday after their worst week in nearly two years. The Dow Jones Industrial Average and the S&P 500 both climbed over 1.30%. Still, analysts are divided over whether the recent sell-off is over just yet.
Ensign Group (ENSG) Beats on Q4 Earnings, Raises '18 View
by Zacks Equity Research
Ensign Group's (ENSG) top line rises in Q4 on solid segmental revenues.
Humana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View
by Zacks Equity Research
Humana's (HUM) solid fourth-quarter results were driven by strong performance of Retail and Group & Specialty segments.
WellCare Health (WCG) Beats Q4 Earnings, Raises '18 View
by Zacks Equity Research
Solid organic and inorganic growth drives WellCare Health's (WCG) fourth-quarter results. However, higher expenses act as partial offset.
Can Solid Retail Segment Drive Humana's (HUM) Q4 Earnings?
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to gain from solid premium growth, especially in the Retail segment.
Cigna Q4 Earnings Top on Higher Enrollment, 2018 View Issued
by Zacks Equity Research
Cigna (CI) Q4 earnings grow on higher revenues, which gained from higher premium and fees and increase in membership.
Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View
by Zacks Equity Research
Anthem (ANTM) reported strong fourth-quarter results on the back of solid performance across its segments.
Anthem's (ANTM) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter earnings surpass Zacks Consensus Estimate by 3.2%.
Aetna (AET) Q4 Earnings Top Estimates, Enrollment Declines
by Zacks Equity Research
Aetna (AET) results suffered from lower enrollment, investment spending and favorable development of prior-year health cost.
5 Low Leverage Stocks to Save Your Portfolio From Debt Traps
by Zacks Equity Research
Since companies with large debt loads are prone to bankruptcy at times of economic crisis, risk-averse investors should go for low leverage stocks.
Anthem (ANTM) Q4 Earnings: Is a Beat in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter earnings are likely to gain from top-line appreciation driven by enrollment growth.
Will Lower Revenues Weigh on Aetna's (AET) Q4 Earnings?
by Zacks Equity Research
Aetna's (AET) Q4 earnings are likely to be adversely impacted by lower revenues from the healthcare segment and a decline in membership.
AET vs. HCA: Which Stock is Poised for Better Q4 Earnings?
by Zacks Equity Research
Let us try to find out which stock between Aetna (AET) and HCA Healthcare (HCA) is better positioned for an earnings beat in the fourth quarter
Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem
by Zacks Equity Research
Zacks Industry Outlook Highlights: Aetna, Humana, Cigna and Anthem
Will HCA Healthcare's (HCA) Earnings Beat Estimates in Q4?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results are expected to be driven by higher admissions
Can Molecular Diagnostics Drive Myriad's (MYGN) Q2 Earnings?
by Zacks Equity Research
Myriad (MYGN) positioned to deliver solid Q2 results on the diversified Molecular Diagnostics portfolio with products like GeneSight and EndoPredict tests.
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth, Humana, Cigna, Anthem and Centene
Disruptive Forces to Keep Health Insurers on Their Toes
by Zacks Equity Research
The year 2018 should be lined with continued policy changes and ongoing uncertainty for health insurers.
Health Insurers Bask Under Rising Insured, Medicare Business
by Zacks Equity Research
Health insurers have capitalized on a surge in insured rates by raking in members, who added to their top-line growth.
Health Insurance Stock Outlook - January 2018
by Zacks Equity Research
Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.
4 Great Healthcare Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
An ageing population and steady demand for healthcare services continue to make stocks from the sector a lucrative option.
UnitedHealth (UNH) Beats on Q4 Earnings, Revises 2018 View
by Zacks Equity Research
UnitedHealth (UNH) Q4 earnings reflect broad-based growth across both its segments.